Adalimumab vs Allopurinol

## Adalimumab vs Allopurinol: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Allopurinol**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Allopurinol**: Xanthine oxidase inhibitor reducing uric acid production.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Allopurinol — 1-2 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Allopurinol — C5H4N4O.

**Molecular Weight**: Adalimumab — N/A; Allopurinol — 136.1120 g/mol.

**Type**: Adalimumab — Antibody; Allopurinol — Small molecule.